دورية أكاديمية
The efficacy and safety of tinengotinib in patients with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC).
العنوان: | The efficacy and safety of tinengotinib in patients with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC). |
---|---|
المؤلفون: | Hongqian, Guo, Subudhi, Sumit Kumar, Han, Weiqing, Liao, Chih-Yi, Zhang, Shun, Dai, Tao, Peng, Peng, Sun, Caixia, Wang, Hui, Hennessy, Katie, Fu, Ximei, Yu, Yingying, Wu, Yingtong, Li, Qing, Xu, Ruolan, Huang, Peng, Neo, Levin, Wu, Frank, Fan, Jean, Piha-Paul, Sarina A. |
المصدر: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p133-133, 235p |
قاعدة البيانات: | Supplemental Index |
كن أول من يترك تعليقا!